[ad_1] Read the article The United States Food and Drug Administration extends the Enforcement Discretionary Policy for certain Cell, Tissue, and Human Cell and Tissue (HCT / P) products. Due to the challenges presented by the COVID-19 public health emergency, the FDA is expanding its enforcement discretion policy that will …

Read More »